Sign inJoin waitlistJoin the waitlist

Philip McCarthy

Director Emeritus of the Transplant & Cellular Therapy Center · ROSWELL PARK CANCER INSTITUTE

Credentials: · · · · ·

History

Transplant & Cellular Therapy Center · ROSWELL PARK CANCER INSTITUTE
Present
University at Buffalo School of Medicine
Present
University at Buffalo School of Medicine
Present

Hematology and Medical Oncology
Brigham and Women's Hospital
1985–1988
Yale-New Haven Hospital
1982–1985
Tufts University School of Medicine
1978–1982

Research

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Review · The Lancet Oncology · 2016 · 2,602 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · First of 40 authors · Corresponding · 909 citations
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Blood · 2015 · 676 citations

Hillard Lazarus
52 papers
Marcelo Pasquini
46 papers
Mary Horowitz
38 papers
Daniel Weisdorf
32 papers
Sarah Holstein
30 papers
MB
Minocher Battiwalla
29 papers
SG
Sergio Giralt
29 papers
George Chen
28 papers
Richard Maziarz
28 papers
Jens Hillengass
27 papers
GH
Gregory Hale
25 papers
MR
Maureen Ross
23 papers

Clinical trials

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant
Principal investigator · Completed · Phase 2
Roswell Park Cancer Institute
2019–2022
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Principal investigator · Terminated · Phase 2
Roswell Park Cancer Institute
2017–2023
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
Principal investigator · Active not recruiting · Phase 1, Phase 2
Roswell Park Cancer Institute
2017–2032
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Principal investigator · Withdrawn
Roswell Park Cancer Institute
2012